| Members |
targetComponentId |
| Carbidopa 25mg |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug) |
| carbidopa 25 mg + levodopa 100 mg oralt opløselig tablet |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
| carbidopa 25 mg + levodopa 250 mg oralt opløselig tablet |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet |
| Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet |
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet |
| carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 1 mg/1 ml/4 mg/1 ml/15 mg/1 ml dråber |
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) |
| carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml/12,5 mg/5 ml/60 mg/5 ml syrup |
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
| carbinoxaminmaleat 4 mg/5 ml + dextromethorphanhydrobromid 15 mg/5 ml + pseudoephedrinhydrochlorid 60 mg/5 ml syrup |
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
| carbinoxaminmaleat + pseudoephedrinhydrochlorid 1 mg/1 ml/15 mg/1 ml dråber |
Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution |
| carbinoxaminmaleat + pseudoephedrinhydrochlorid 8 mg/120 mg tablet med modificeret udløsning |
Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form) |
| Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg prolonged-release oral tablet |
Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form) |
| Carbohydrate agent |
Carbohydrate |
| Carbol fuchsin stain |
Carbol-fuchsin (substance) |
| Carbon-carbon lyase |
Carbon-carbon lyase |
| Carbon-halide lyase |
Carbon-halide lyase |
| Carbon-nitrogen lyase |
Carbon-nitrogen lyase |
| Carbon-oxygen lyase |
Carbon-oxygen lyase |
| Carbon-sulfur lyase |
Carbon-sulfur lyase |
| Carboplatin 600mg/60mL infusion |
Antineoplastic agent (substance) |
| Carboxy-lyase |
Decarboxylase |
| Carboxylic ester hydrolase |
Carboxylesterase |
| carboxymethylcellulosenatrium + hydroxyapatit, injicerbart implantat, sprøjte a 1 ml |
Carmellose and hydroxyapatite only product in parenteral dose form |
| carboxymethylcellulosenatrium 16,58 % oral pasta |
Carmellose 166 mg/g oromucosal paste |
| Carbuncle of head, except face |
Carbuncle of head (disorder) |
| Carbuncle of other specified site |
Carbuncle of skin and/or subcutaneous tissue (disorder) |
| Karcinoidt bronkialt adenom |
Carcinoid tumour of bronchus |
| Carcinoid bronchial adenoma |
Well-differentiated neuroendocrine tumor (morphologic abnormality) |
| karcinoid tumor |
Well-differentiated neuroendocrine tumour |
| Karcinoid tumor, morfologi |
Well-differentiated neuroendocrine tumor (morphologic abnormality) |
| karcinoid tumor med undtagelse af appendix |
Well-differentiated neuroendocrine tumor (morphologic abnormality) |
| Karcinoid tumor i ampulla hepatopancreatica |
Well-differentiated neuroendocrine tumor of ampulla of Vater (disorder) |
| Karcinoid tumor i appendix |
Well-differentiated neuroendocrine tumor of appendix (disorder) |
| karcinoid tumor i mave-tarm-kanalen |
Well-differentiated neuroendocrine tumor of gastrointestinal tract |
| karcinoid tumor i ileum |
Well-differentiated neuroendocrine tumor of ileum |
| Karcinoid tumor i tarm |
Well-differentiated neuroendocrine tumour of intestine |
| Karcinoid tumor i tyktarm |
Well-differentiated neuroendocrine tumor of large intestine |
| Karcinoid tumor i pancreas |
Neuroendocrine tumor of pancreas (disorder) |
| Carcinoid tumor of rectum |
Well-differentiated neuroendocrine tumour of rectum |
| Karcinoid tumor i tyndtarm |
Well-differentiated neuroendocrine tumor of small intestine (disorder) |
| karcinoid tumor i mavesækken |
Well-differentiated neuroendocrine tumour of stomach |
| karcinoid tumor med usikkert malignt potentiale |
Well-differentiated neuroendocrine tumor (morphologic abnormality) |
| carcinoma in situ iht. kategori |
Carcinoma in situ (morphologic abnormality) |
| Carcinoma in situ NOS |
Carcinoma in situ (disorder) |
| Carcinoma in situ NOS |
Carcinoma in situ (disorder) |
| Carcinoma in situ neoplastic process |
Carcinoma in situ (morphologic abnormality) |
| carcinoma in situ i areola mammae hos kvinde |
Carcinoma in situ of areola (disorder) |
| carcinoma in situ i areola mammae hos mand |
Carcinoma in situ of areola (disorder) |
| carcinoma in situ i processus axillaris i mamma hos kvinde |
Carcinoma in situ of axillary tail of breast |
| carcinoma in situ i central del af mamma hos kvinde |
Carcinoma in situ of central portion of breast (disorder) |
| carcinoma in situ i ektopisk mammavæv hos kvinde |
Carcinoma in situ of ectopic site of breast (disorder) |
| carcinoma in situ i ektopisk brystvæv hos mand |
Carcinoma in situ of ectopic site of breast (disorder) |
| carcinoma in situ i mamma hos kvinde |
Carcinoma in situ of breast |
| carcinoma in situ i nedre mediale kvadrant af mamma hos kvinde |
Carcinoma in situ of lower inner quadrant of breast |
| carcinoma in situ i nedre laterale kvadrant af mamma hos kvinde |
Carcinoma in situ of lower outer quadrant of breast (disorder) |
| carcinoma i situ i mamma hos mand |
Carcinoma in situ of breast |
| carcinoma in situ i brystvorte hos kvinde |
Carcinoma in situ of nipple (disorder) |
| carcinoma in situ i brystvorte hos mand |
Carcinoma in situ of nipple (disorder) |
| Carcinoma in situ of other and unspecified female genital organs |
Carcinoma in situ of female genital organ |
| Carcinoma in situ i andre og uspecificerede kvindelige kønsorganer |
Carcinoma in situ of female genital organ |
| Carcinoma in situ of other and unspecified male genital organs |
Carcinoma in situ of male genital organ |
| Carcinoma in situ i andre og uspecificerede mandlige kønsorganer |
Carcinoma in situ of male genital organ |
| Carcinoma in situ i andre og uspecificerede dele af ansigtshuden |
Carcinoma in situ of skin of face |
| Carcinoma in situ of skin of other and unspecified parts of face |
Carcinoma in situ of skin of face |
| Carcinoma in situ of skin of other and unspecified parts of face NOS |
Carcinoma in situ of skin of face |
| carcinoma in situ i øvre mediale kvadrant af mamma hos kvinde |
Carcinoma in situ of upper inner quadrant of breast |
| carcinoma in situ i øvre laterale kvadrant af mamma hos kvinde |
Carcinoma in situ of upper outer quadrant of breast |
| Carcinoma in situ tumour |
Carcinoma in situ (disorder) |
| carcinoma in situ uden specifikation |
Carcinoma in situ (morphologic abnormality) |
| karcinom i lever-/galdesystem, ikke nærmere specificeret |
Carcinoma liver and/or biliary system (disorder) |
| cervixkarcinom stadium 0 |
Carcinoma in situ of uterine cervix |
| Carcinoma of genital organs NOS |
Carcinoma of genital organ (disorder) |
| Carcinoma of genital organs NOS |
Carcinoma of genital organ (disorder) |
| karcinom i mamma hos mand |
Carcinoma of breast |
| fund vedr. hudkarcinom (bortset fra øjenlåg, vulva, penis og melanomer) udtrykt ved TNM-systemet |
American Joint Committee on Cancer allowable value |
| Karcinom som minder om mammakarcinom |
Carcinoma (morphologic abnormality) |
| karcinom |
Carcinoma (morphologic abnormality) |
| incision med kardiel adgang |
Making a cut in something |
| Cardiac arrest, unspecified |
Cardiac arrest (disorder) |
| Hjertestop, uspecificeret |
Cardiac arrest (disorder) |
| Cardiac disease monitoring NOS |
Cardiac disease monitoring |
| Cardiac disease monitoring NOS |
Cardiac disease monitoring |
| hjertearytmi, ikke nærmere specificeret |
A disorder in which there is abnormal electrical activity in the heart. |
| Cardiac dysrhythmia NOS |
A disorder in which there is abnormal electrical activity in the heart. |
| Cardiac end diastolic volume, function (observable entity) |
Cardiac end-diastolic volume (observable entity) |
| Cardiac enzymes NOS |
Cardiac enzymes/isoenzymes measurement |
| Cardiac enzymes NOS |
Cardiac enzymes/isoenzymes measurement |
| Cardiac function tests NOS |
Cardiac function testing |
| Cardiac function tests NOS |
Cardiac function testing |
| bivirkning af kardielt glycosid |
Adverse reaction to Digitalis glycoside |
| Cardiac pacing NOS |
Cardiac pacing |
| Kardiel pacing, ikke nærmere specificeret |
Cardiac pacing |
| Cardiac status not worse than preoperative baseline |
Cardiac status is consistent with or improved from preoperative baseline (finding) |
| Cardio-oesophageal X-ray |
Plain X-ray of cardioesophageal junction with contrast |
| Kardioøsofageal røntgenundersøgelse |
Plain X-ray of cardioesophageal junction with contrast |
| kardiologisk behandling |
Cardiology service (qualifier value) |
| Cardiomyopathy NOS |
Cardiomyopathy |
| Kardiomyopati, ikke nærmere specificeret |
Cardiomyopathy |
| kardiomyopati forårsaget af lægemidler og andree eksterne agenser |
Cardiomyopathy caused by drug |
| kardioplegisk perfusionopløsning |
Cardioplegic solution agent (substance) |
| kardioplegisk opløsning |
Cardioplegic solution agent (substance) |
| Kardiovaskulær angiografi, ikke nærmere specificeret |
Angiocardiography |
| Cardiovascular angiography NOS |
Angiocardiography |
FHIR